![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Molecular Devices Buys Xsira's Imaging Technology
Molecular Devices Buys Xsira's Imaging Technology
March 10, 2005
The complete portfolio of Transfluor technology assets has been purchased from Xsira Pharmaceuticals for $11 million in cash by Molecular Devices, which makes bioanalytical tools. The technology, comprising proprietary assays that operate on imaging platforms such as Molecular Devices' Discovery-1 and ImageXpress systems, offers a way to visualize key cellular events and to detect receptor activation, according to Molecular of Sunnyvale, Calif.
Silicon Valley/San Jose Business Journal (http://sanjose.bizjournals.com/sanjose/stories/2005/03/07/daily31.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct